Advinus, Takeda deal

Advinus received a $3 million milestone payment from Takeda under a 2012 deal to discover compounds against predefined undisclosed targets for inflammation, CNS and metabolic diseases. Advinus said this is the "first year milestone" under the deal. The companies could not be reached for details. ...